Specimen Collection for the Evaluation of Alere NT-proBNP for Alinity i System in an Emergency Department Setting for Heart Failure (LANER-HF)

General Information Age Group Adults Status Active Protocol Number 09DY-02-21A01-01 Background Information The purpose of this research is to collect blood specimens to evaluate a new diagnostic blood test that will help physicians diagnose individuals that may have new symptoms of heart failure or to determine the severity in those with heart failure, better than they can today. Your sample will be used to evaluate the usefulness and clinical utility of cardiac markers, specifically NT-proBNP in patients with heart failure. The new test being evaluated is investigational and not approved by the Food and Drug Administration (FDA). Offered At Inova Fairfax Hospital 3300 Gallows Rd. Falls Church, VA 22042 Principal Investigator Christopher deFilippi, MD Eligibility Information Subjects presenting with signs or symptoms consistent with a clinical suspicion of new onset or acute exacerbation of heart failure. Ineligibility Information Severe renal insufficiency (Stage 4 and 5 CKD; eGFR < 30 mL/min/1.73m2) requiring dialysis. Dyspnea after chest trauma. Prior participation in this study or current participation in an investigational drug study (with the exception of other IVD blood tests) Contact Information Contact Name Chris Anaya Contact Phone 703-776-4782 Contact Email Send Email